Washington roundup: McConnell to House; vote on stand-alone device tax repeal March 27, 2013 By Mark McCarty
AdreView approved for risk evaluation in HF patients March 27, 2013 By Amanda Pedersen GE Healthcare (Princeton, New Jersey) reported FDA approval of a new indication for AdreView (Iobenguane I 123 Injection), a molecular imaging agent, to link nerve function in the heart to a patient's mortality risk. Read More
RSS